Details for New Drug Application (NDA): 070064
✉ Email this page to a colleague
NDA 070064 describes SULMEPRIM PEDIATRIC, which is a drug marketed by Usl Pharma and is included in one NDA. Additional details are available on the SULMEPRIM PEDIATRIC profile page.
The generic ingredient in SULMEPRIM PEDIATRIC is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
The generic ingredient in SULMEPRIM PEDIATRIC is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
Summary for 070064
| Tradename: | SULMEPRIM PEDIATRIC |
| Applicant: | Usl Pharma |
| Ingredient: | sulfamethoxazole; trimethoprim |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 200MG/5ML;40MG/5ML | ||||
| Approval Date: | Aug 1, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
